For: | Tacke F, Luedde T, Manns MP, Trautwein C. Regulation of plasma erythropoietin in chronic liver disease. World J Gastroenterol 2004; 10(19): 2922-2923 [PMID: 15334703 DOI: 10.3748/wjg.v10.i19.2922] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i19/2922.htm |
Number | Citing Articles |
1 |
Zainab M.A. Anis, Amira Y. Ahmed, Hanan H. Soliman, Hala M. Nagy. Serum growth differentiation factor 15 levels as a marker for liver cirrhosis and hepatocellular carcinoma on top of liver cirrhosis. Tanta Medical Journal 2022; 50(4): 251 doi: 10.4103/tmj.tmj_173_20
|
2 |
Frank Tacke, Christian Trautwein, Eray Yagmur, Claus Hellerbrand, Reiner Wiest, David A Brenner, Bernd Schnabl. Up‐regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course. Journal of Gastroenterology and Hepatology 2007; 22(8): 1256 doi: 10.1111/j.1440-1746.2006.04621.x
|
3 |
Saeedeh Yarjou, Omid Sadeghpour, Esmail Nazem, Amir Hossein Emami. Liver Function and Anemia Pathogenesis in Iranian Traditional Medicine. Iranian Red Crescent Medical Journal 2014; 16(12) doi: 10.5812/ircmj.17099
|
4 |
Frank Tacke, Christian Trautwein. A reply to Siciliano et al.. Scandinavian Journal of Gastroenterology 2005; 40(1): 124 doi: 10.1080/00365520510012325
|
5 |
Cosimo Marcello Bruno, Claudio Sciacca, Danila Cilio, Gaetano Bertino, Rinaldo Pellicano. Erythropoietin in liver cirrhosis: Two questions without answers. World Journal of Gastroenterology 2005; 11(23): 3649-3649 doi: 10.3748/wjg.v11.i23.3649
|